Asante Ceases Operations, Asks Animas To Transition Customers

I don't normally do this, but this is important for owners of Asante "Snap" insulin pumps and even if few people with type 2 diabetes might be using one, this needs to be brought to every one's attention.  The following is from an email I received 7:32 PM CDT.

On behalf of Johnson & Johnson Diabetes Solutions Companies (JJDSC), we wanted to share with you some important industry news.  Today at 5:30 PM PST, Asante Solutions announced to its customers via email that it is ceasing all business operations and will no longer sell or support the Asante Snap Insulin Pump.  This means all current Asante Snap Insulin Pump users will soon need to transition to a new insulin pump.

Just before this announcement, the leadership of Asante specifically asked Animas to assist their customers through this transition, and we’ve agreed to help.  We understand how disappointing and frustrating it can be for patients to unexpectedly have to go through the process of finding a new insulin pump and company that will meet their needs. 

Our goal is to help every Asante Snap Insulin Pump user receive a new Animas Insulin Pump as quickly and easily as possible. 

To start the process of receiving a replacement Animas Insulin Pump, we are asking all Asante Snap pump patients to call toll free 1-877-937-7867 X1562.  Our Customer Care Representatives are available to assist them Monday – Friday, 8:00 AM – 8:00 PM EST.

In order to reach as many Asante Snap customers as possible, we would appreciate you sharing information about this replacement program with your readers/followers.

Because this is such a new development, we are continuing to work through the details of this replacement program while we begin to help Asante Snap customers through their transition. Please be patient if we are not able to answer all of your questions about the program at this time.  More information will be provided as soon as it is available.  In the interim, you can direct any questions to JJDSC Communications Director Dave Detmers via the contact information below.

Regards,

The JJDSC Communications Team

Dave Detmers

Director, Communications

Johnson & Johnson Diabetes Solutions Companies

ddetmers@its.jnj.com

Or you can go to the Asante website here and read the announcement.